Pentax Europe GmbH:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Pentax Europe GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10485
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corp, is a medical device company that offers clinical endo-imaging solutions. The company provides products in the therapeutic areas of gastroenterology, endoscopic ultrasound, ENT and speech, pulmonology and urology, among others. It offers products such as gastroscopes, duodenoscopes, small bowel enteroscopes, colonoscopes, linear array and radial array ultrasound endoscopes, bronchoscopes, intubation scopes and cytoscope, among others. Pentax Medical also offers advanced imaging, video equipment and accessories peripherals, among others. The company provides consulting and analytics services which delivers consultative support in the areas of damage prevention and endoscope handling, disinfection and reprocessing, repair analysis, and others. Pentax Medical is headquartered in Hamburg, Germany.

Pentax Europe GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pentax Europe GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pentax Europe GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pentax Europe GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pentax Europe GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Pentax Europe GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pentax Europe GmbH, Medical Equipment, Deal Details 10
Venture Financing 10
Creo Medical Raises USD8.5 Million Financing 10
Partnerships 11
Creo Medical Enters into Distribution Agreement with Pentax Medical 11
PENTAX Medical Enters in Distribution Agreement with Avantis Medical Systems 12
CapsoVision Enters into Distribution Agreement with PENTAX Medical 13
PENTAX Medical and Shanghai AoHua Photoelectricity Endoscope Form Joint Venture 14
Smart Medical Systems Enters Into Commercialization Agreement With Pentax Medical 15
PENTAX Medical Expands Co-Development Agreement with Hitachi-Aloka Medical 16
SpectraScience And Pentax Europe Expand Distribution Agreement For WavStat4 Optical Biopsy System 17
SpectraScience Enters Into Distribution Agreement With Pentax Europe 18
PENTAX Medical Enters into Licensing Agreement with American Speech-Language-Hearing Association 19
Acquisition 20
PENTAX Medical Acquires Majority Stake in PlasmaBiotics 20
PENTAX Medical Acquires C2 Therapeutics 21
Pentax Acquires Additional Stake in Sistemas Integrales de Medicina 22
Pentax Europe Acquires Remaining Stake in Pentax Italia from Movi 23
Pentax Europe GmbH – Key Competitors 24
Pentax Europe GmbH – Key Employees 25
Pentax Europe GmbH – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Pentax Europe GmbH, Medical Equipment, Key Facts 2
Pentax Europe GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Pentax Europe GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pentax Europe GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pentax Europe GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pentax Europe GmbH, Deals By Market, 2012 to YTD 2018 8
Pentax Europe GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Creo Medical Raises USD8.5 Million Financing 10
Creo Medical Enters into Distribution Agreement with Pentax Medical 11
PENTAX Medical Enters in Distribution Agreement with Avantis Medical Systems 12
CapsoVision Enters into Distribution Agreement with PENTAX Medical 13
PENTAX Medical and Shanghai AoHua Photoelectricity Endoscope Form Joint Venture 14
Smart Medical Systems Enters Into Commercialization Agreement With Pentax Medical 15
PENTAX Medical Expands Co-Development Agreement with Hitachi-Aloka Medical 16
SpectraScience And Pentax Europe Expand Distribution Agreement For WavStat4 Optical Biopsy System 17
SpectraScience Enters Into Distribution Agreement With Pentax Europe 18
PENTAX Medical Enters into Licensing Agreement with American Speech-Language-Hearing Association 19
PENTAX Medical Acquires Majority Stake in PlasmaBiotics 20
PENTAX Medical Acquires C2 Therapeutics 21
Pentax Acquires Additional Stake in Sistemas Integrales de Medicina 22
Pentax Europe Acquires Remaining Stake in Pentax Italia from Movi 23
Pentax Europe GmbH, Key Competitors 24
Pentax Europe GmbH, Key Employees 25
Pentax Europe GmbH, Other Locations 26
Pentax Europe GmbH, Subsidiaries 26

List of Figures
Pentax Europe GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Pentax Europe GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Pentax Europe GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Pentax Europe GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Pentax Europe GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pentax Europe GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Pentax Europe GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pentax Europe GmbH, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Pentax Europe GmbH:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報
    Summary The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) is a healthcare center that provides blood-based biomarker tests. The center conducts biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease and biomarkers in tra …
  • Reliance Communications Ltd (RCOM):企業の財務・戦略的SWOT分析
    Reliance Communications Ltd (RCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Provenance Biopharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Provenance Biopharmaceuticals Corp (Provenance) is a biotechnology company that develops various novel immunotherapeutic drugs to treat cancer and other serious, life-threatening diseases. The company offers cancer drugs based on antibodies which include avastin, erbitux, hercepton, and ritu …
  • Quanta Computer Inc (2382):企業の財務・戦略的SWOT分析
    Quanta Computer Inc (2382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Apollo Hospitals Enterprise Ltd (APOLLOHOSP):製薬・医療:M&Aディール及び事業提携情報
    Summary Apollo Hospitals Enterprise Ltd (Apollo Hospitals) is a healthcare service provider. It offers healthcare services, clinical and diagnostic services, medical business process outsourcing, third party administration services and health insurance. The company also provides services to support …
  • Massachusetts General Hospital:医療機器:M&Aディール及び事業提携情報
    Summary Massachusetts General Hospital (MGH) is a healthcare service provider which offers research, education and therapeutic care services. The hospital provides treatment and patient care services in the therapeutic areas of allergy and immunology; hematology, orthopaedics, neurology and neurosur …
  • Saline Water Conversion Corp:発電所・企業SWOT分析
    Saline Water Conversion Corp - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Grupo Biotoscana SL (GBIO33):製薬・医療:M&Aディール及び事業提携情報
    Summary Grupo Biotoscana SL (Biotoscana) is a biopharmaceutical company that develops, manufactures and markets advanced medicines for unmet medical needs. The company offers products such as vidaza, ladevina, zyvalix, mielozitidina, votrynib, bozob, timab, enzastar, capebina, leprid, olvestran, toc …
  • RayBiotech Inc-医療機器分野:企業M&A・提携分析
    Summary RayBiotech Inc (RayBiotech) is a life science company that offers proteins, antibodies and immunological kits. The company’s products include antibody arrays, elisa, functional assays, antibodies and custom recombinant protein service. It provides services such as testing services, custom se …
  • Shinsei Bank Ltd:企業のM&A・事業提携・投資動向
    Shinsei Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shinsei Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Enterprise Ireland:企業のM&A・事業提携・投資動向
    Enterprise Ireland - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Enterprise Ireland Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • IDOX Plc (IDOX):企業の財務・戦略的SWOT分析
    Summary IDOX Plc (IDOX) is an information technology company that supplies and develops software solutions and information services. The company offers services such as funding, manages services, government and compliance solutions. Its government services include environmental, legal, democratic, e …
  • BoneSupport AB:企業の製品パイプライン分析
    Summary BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; diseas …
  • W.W. Grainger, Inc.:企業の戦略・SWOT・財務分析
    W.W. Grainger, Inc. - Strategy, SWOT and Corporate Finance Report Summary W.W. Grainger, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tuesday Morning Corporation (TUES):企業の財務・戦略的SWOT分析
    Tuesday Morning Corporation (TUES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Pakistan Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pakistan Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pakistan Petroleum Ltd (PPL) is an upstream oil and gas company. It explores, develops and produces crude oil and natural gas resources. The company operates producing fields at Sui, Kandhkot, Adh …
  • Grand Gulf Energy Ltd (GGE):企業の財務・戦略的SWOT分析
    Summary Grand Gulf Energy Ltd (GGE), formerly Alto Energy International Ltd, is an oil and gas exploration and production company. It acquires, explores and develops conventional oil and gas assets in the US oil and gas basins. In addition, GGE also holds interests in Napoleonville Salt Dome project …
  • Standard Chem & Pharm Co Ltd:企業の戦略・SWOT・財務情報
    Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • China Construction Bank Corp
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Asahi Kasei Pharma Corp-製薬・医療分野:企業M&A・提携分析
    Summary Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. The company's portfolio encompasses prescription drugs, diagnostic reagents, and enzymes for diagnostic reagents. Its prescr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆